Taro Pharmaceutical Industries Ltd (TARO)
42.21
-0.02
(-0.05%)
USD |
NYSE |
Apr 24, 16:00
42.21
0.00 (0.00%)
After-Hours: 20:00
Taro Pharmaceutical Industries Price to Book Value: 0.8917 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 23, 2024 | 0.8921 |
April 22, 2024 | 0.8928 |
April 19, 2024 | 0.8926 |
April 18, 2024 | 0.8913 |
April 17, 2024 | 0.8924 |
April 16, 2024 | 0.8883 |
April 15, 2024 | 0.8898 |
April 12, 2024 | 0.8881 |
April 11, 2024 | 0.89 |
April 10, 2024 | 0.8881 |
April 09, 2024 | 0.8913 |
April 08, 2024 | 0.8879 |
April 05, 2024 | 0.89 |
April 04, 2024 | 0.89 |
April 03, 2024 | 0.8936 |
April 02, 2024 | 0.89 |
April 01, 2024 | 0.8921 |
March 28, 2024 | 0.8945 |
March 27, 2024 | 0.8928 |
March 26, 2024 | 0.8902 |
March 25, 2024 | 0.8924 |
March 22, 2024 | 0.8892 |
March 21, 2024 | 0.8913 |
March 20, 2024 | 0.8943 |
March 19, 2024 | 0.8898 |
Date | Value |
---|---|
March 18, 2024 | 0.886 |
March 15, 2024 | 0.8902 |
March 14, 2024 | 0.8894 |
March 13, 2024 | 0.8902 |
March 12, 2024 | 0.8866 |
March 11, 2024 | 0.8879 |
March 08, 2024 | 0.8879 |
March 07, 2024 | 0.8898 |
March 06, 2024 | 0.8655 |
March 05, 2024 | 0.8864 |
March 04, 2024 | 0.8883 |
March 01, 2024 | 0.8894 |
February 29, 2024 | 0.8888 |
February 28, 2024 | 0.8869 |
February 27, 2024 | 0.89 |
February 26, 2024 | 0.889 |
February 23, 2024 | 0.8885 |
February 22, 2024 | 0.89 |
February 21, 2024 | 0.8909 |
February 20, 2024 | 0.8928 |
February 16, 2024 | 0.8911 |
February 15, 2024 | 0.8938 |
February 14, 2024 | 0.8915 |
February 13, 2024 | 0.8932 |
February 12, 2024 | 0.8947 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5066
Minimum
Mar 28 2023
2.199
Maximum
Apr 26 2019
1.178
Average
1.201
Median
Nov 22 2021
Price to Book Value Benchmarks
InspireMD Inc | 1.128 |
Ayala Pharmaceuticals Inc | -- |
BiomX Inc | 5.798 |
Alpha Tau Medical Ltd | 2.062 |
Pluri Inc | 6.108 |
Price to Book Value Related Metrics
PE Ratio | 34.60 |
PS Ratio | 2.597 |
Price to Free Cash Flow | 18.45 |
Price | 42.21 |
Earnings Yield | 2.89% |
Market Cap | 1.586B |
Operating PE Ratio | 72.19 |
Normalized PE Ratio | 34.66 |